Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
![]() |
Characteristics and Outcome of Pediatric Patients With Renal Cell Carcinoma Registered in International Society of Pediatric Oncology Renal Tumor Study Group 93-01 and 2001/UK-Import DatabasesVan der Beek, JN ; Hol, JA ; Coulomb-L'Hermine, A ; Graf, N ; Van Tinteren, H ; Pritchard-Jones, K ; Houwing, ME ; DeKrijger, RR ; Vujanic, GM ; Dzhuma, K ; Littooij, AS ; Ramirez-Villar, GL ; Murphy, D ; Ray, S ; Al-Saadi, R ; Gessler, M ; Godzinski, J ; Ruebe, C ; Collini, P ; Verschuur, AC ; Frisk, T ; Vokuhl, C ; Hulsbergen-Van De Kaa, CA ; De Camargo, B ; Sandstedt, B ; Selle, B ; Tytgat, G ; Van den Heuvel-Eibrink, MMPEDIATRIC BLOOD & CANCER, 2020, Vol.67, p.S276 [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Ata de Congresso
|
![]() |
OUTCOME OF BLASTEMAL TYPE NEPHROBLASTOMA PATIENTS TREATED ACCORDING TO INTENSIFIED TREATMENT IN THE SIOP 2001 PROTOCOL, A REPORT OF THE SIOP RENAL TUMOUR STUDY GROUP (RTSG)Van den Heuvel-Eibrink, MM ; Van Tinteren, H ; Bergeron, C ; Coulombe, A ; De Camargo, B ; Leuschner, I ; Sandstedt, B ; Acha, T ; Gooskens, SL ; Furtwaengler, R ; De Kraker, J ; Vujanic, GM ; Pritchard-Jones, K ; Graf, NPEDIATRIC BLOOD & CANCER, 2013, Vol.60, p.22 [Periódico revisado por pares]Texto completo disponível |
3 |
Material Type: Ata de Congresso
|
![]() |
CLEAR CELL SARCOMAOF THE KIDNEY (CCSK) REGISTERED ON SIOP 93-01 AND SIOP 2001 PROTOCOLS: A REPORT OF THE SIOP RENAL TUMOUR STUDY GROUPGooskens, SL ; Furtwaengler, R ; Van Tinteren, H ; De Kraker, J ; Schleiermacher, G ; Bergeron, C ; Spreafico, F ; De Camargo, B ; Acha, T ; Godzinski, J ; Sandstedt, B ; Leuschner, I ; Vujanic, G ; Pieters, R ; Graf, N ; Van den Heuvel-Eibrink, MMPEDIATRIC BLOOD & CANCER, 2013, Vol.60, p.22 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Ata de Congresso
|
![]() |
IS THE ABSOLUTE BLASTEMA VOLUME AFTER PREOPERATIVE CHEMOTHERAPY IN NEPHROBLASTOMA RELEVANT FOR PROGNOSIS?Graf, N ; van Tinteren, H ; Pritchard-Jones, K ; Bergeron, C ; Sandstedt, B ; Leuschner, I ; Vujanic, G ; Boccon-Gibod, L ; van den Heuvel-Eibrink, M ; de Camargo, B ; Spreafico, F ; Oldenburger, F ; Godzinski, J ; de Kraker, JPEDIATRIC BLOOD & CANCER, 2011, Vol.57 (5), p.741 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Ata de Congresso
|
![]() |
DOXORUBICIN CAN BE SAFELY OMITTED FROM THE TREATMENT OF STAGE II/III, INTERMEDIATE RISK HISTOLOGY WILMS TUMOUR: RESULTS OF THE SIOP WT 2001 RANDOMISED TRIALPritchard-Jones, K ; Graf, N ; Bergeron, C ; de Camargo, B ; van den Heuvel, M ; Sandstedt, B ; Leuschner, I ; Vujanic, G ; Boccon-Gibod, L ; Godzinski, J ; Oldenburger, F ; van Tinteren, H ; de Kraker, JPEDIATRIC BLOOD & CANCER, 2011, Vol.57 (5), p.741 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Ata de Congresso
|
![]() |
RHABDOID TUMOURS OF THE KIDNEY (RTK) TREATED ACCORDING TO RECENT STOP PROTOCOLS, ON BEHALF OF THE SIOP RTSGvan den Heuvel-Eibrink, M ; van Tinteren, H ; Bergeron, C ; de Camargo, B ; Graf, N ; de Kraker, J ; Leuschner, I ; Lugtenberg, R ; Pritchard-Jones, K ; Sandstedt, B ; Spreafico, F ; Vujanic, GPEDIATRIC BLOOD & CANCER, 2009, Vol.53 (5), p.753 [Periódico revisado por pares]Texto completo disponível |